Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMari Iida, Deric L. Wheeler|Molecular Cancer|2014Cited by 64
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancerMari Iida, Deric L. Wheeler|BMC Cancer|2022Cited by 16
AXL Regulates Neuregulin1 Expression Leading to Cetuximab Resistance in Head and Neck CancerMari Iida, Deric L. Wheeler|Research Square|2021Cited by 1